Marburg Lassa Ebola Multiplex Detection and Differentiation RNA Detection Qualitative Test
Comprehensive Viral Hemorrhagic Fever Detection
The Marburg Lassa Ebola Multiplex Detection and Differentiation RNA Detection Qualitative Test represents a breakthrough in molecular diagnostics for identifying and distinguishing between three of the world’s most dangerous viral hemorrhagic fevers. This advanced testing solution utilizes cutting-edge Real-Time PCR technology to provide rapid, accurate detection of Marburg virus, Lassa virus, and Ebola virus RNA in a single comprehensive analysis.
What This Test Measures and Detects
This sophisticated multiplex assay specifically targets and identifies the genetic material (RNA) of:
- Marburg Virus: A highly virulent filovirus causing severe hemorrhagic fever
- Lassa Virus: An arenavirus endemic to West Africa with significant outbreak potential
- Ebola Virus: Multiple species of filoviruses known for causing devastating outbreaks
The test’s qualitative nature provides definitive yes/no results for each virus, enabling precise differentiation crucial for appropriate medical management and public health responses.
Who Should Consider This Test
This critical screening is recommended for individuals who:
- Have traveled to or resided in regions with known outbreaks of these viruses
- Work in healthcare settings with potential exposure to infected patients
- Present with symptoms including high fever, severe headache, muscle pain, vomiting, diarrhea, or unexplained bleeding
- Have had direct contact with individuals diagnosed with viral hemorrhagic fevers
- Work in laboratory settings handling these pathogens
- Experience sudden onset of hemorrhagic symptoms without clear alternative diagnosis
Key Benefits of Early Detection
Timely identification through this multiplex test provides numerous advantages:
- Rapid Diagnosis: Enables immediate implementation of appropriate treatment protocols
- Infection Control: Facilitates proper isolation and containment measures
- Public Health Response: Supports outbreak investigation and contact tracing
- Treatment Guidance: Directs specific antiviral and supportive care strategies
- Peace of Mind: Provides definitive answers for concerned individuals and healthcare providers
Understanding Your Test Results
Your results will clearly indicate the presence or absence of each specific virus:
- Positive Result: Indicates detection of viral RNA, requiring immediate medical consultation and implementation of appropriate infection control measures
- Negative Result: Suggests no detectable viral RNA at the time of testing, though clinical correlation with symptoms and exposure history remains essential
- Inconclusive Result: May require repeat testing or alternative diagnostic approaches
All positive results should be immediately discussed with healthcare providers for proper interpretation and management.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Marburg Lassa Ebola Multiplex Detection and Differentiation RNA Detection Qualitative Test | $290 USD | $340 USD |
Nationwide Testing Availability
GGC DNA maintains testing facilities across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible testing services for patients nationwide.
Take Action Today
Early detection of viral hemorrhagic fevers can be life-saving. Don’t wait until symptoms worsen – schedule your comprehensive multiplex screening today. Our dedicated team is ready to assist you with testing coordination and result interpretation.
Call or WhatsApp us now at +1(267) 388-9828 to book your test or discuss your testing needs with our genetic specialists.
Note: This test requires signed consent documentation and relevant clinical history for proper interpretation. Sample types accepted include whole blood, serum, plasma, CSF, oral fluid, various swabs, body secretions, and other bodily fluids. Results are typically available within 48 hours via email or 36 hours by phone request.